These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 32022598)

  • 1. TSH RECEPTOR ANTIBODIES: RELEVANCE & UTILITY.
    Kahaly GJ; Diana T; Olivo PD
    Endocr Pract; 2020 Jan; 26(1):97-106. PubMed ID: 32022598
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous assay for three types of thyrotropin receptor antibody activities using FRTL-5 cells in patients with autoimmune thyroid diseases.
    Zhu Y; Portmann L; Dénéréaz N; Lemarchand-Béraud T
    Eur J Endocrinol; 1994 Oct; 131(4):359-68. PubMed ID: 7921224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioassays for thyrotropin receptor autoantibodies.
    Olivo PD
    Best Pract Res Clin Endocrinol Metab; 2023 Mar; 37(2):101744. PubMed ID: 36828714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of functional thyrotropin receptor antibodies in Serbian patients with Graves' orbitopathy.
    Sarić Matutinović M; Diana T; Nedeljković Beleslin B; Ćirić J; Žarković M; Kahaly GJ; Ignjatović S
    J Endocrinol Invest; 2022 Jan; 45(1):189-197. PubMed ID: 34324163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin Receptor Blocking Antibodies.
    Diana T; Olivo PD; Kahaly GJ
    Horm Metab Res; 2018 Dec; 50(12):853-862. PubMed ID: 30286485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
    Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical relevance of thyroid stimulating hormone receptor-blocking antibodies in autoimmune thyroid disease.
    Diana T; Krause J; Olivo PD; König J; Kanitz M; Decallonne B; Kahaly GJ
    Clin Exp Immunol; 2017 Sep; 189(3):304-309. PubMed ID: 28439882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Monoclonal Antibody Degrades the Thyrotropin Receptor Autoantibodies in Graves' Disease.
    Wolf J; Alt S; Krämer I; Kahaly GJ
    Endocr Pract; 2023 Jul; 29(7):553-559. PubMed ID: 37080298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a Bridge Immunoassay with Two Bioassays for Thyrotropin Receptor Antibody Detection and Differentiation.
    Allelein S; Diana T; Ehlers M; Kanitz M; Hermsen D; Schott M; Kahaly GJ
    Horm Metab Res; 2019 Jun; 51(6):341-346. PubMed ID: 31207654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.
    Maugendre D; Massart C
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):89-96. PubMed ID: 11167931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
    Morgenthaler NG; Ho SC; Minich WB
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotropin Receptor Antagonism by a Novel Small Molecule: Preclinical
    Kahaly GJ; Steiner L; van der Lee MMC; van Achterberg TAE; Arends RJ; Karstens WFJ; Weirauch T; Henseling J; Frommer L; Wolf J; George A
    Thyroid; 2023 Jun; 33(6):732-742. PubMed ID: 37016815
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of Graves Thyroidal and Extrathyroidal Disease: An Update.
    Kahaly GJ
    J Clin Endocrinol Metab; 2020 Dec; 105(12):3704-20. PubMed ID: 32929476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors.
    Grasso YZ; Kim MR; Faiman C; Kohn LD; Tahara K; Gupta MK
    Thyroid; 1999 Jun; 9(6):531-7. PubMed ID: 10411114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease.
    Lenzner C; Morgenthaler NG
    Thyroid; 2003 Dec; 13(12):1153-61. PubMed ID: 14751037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The phenotype of Graves' orbitopathy is associated with thyrotropin receptor antibody levels.
    Sarić Matutinović M; Kahaly GJ; Žarković M; Ćirić J; Ignjatović S; Nedeljković Beleslin B
    J Endocrinol Invest; 2023 Nov; 46(11):2309-2317. PubMed ID: 37020104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
    Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
    Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor.
    Morgenthaler NG; Pampel I; Aust G; Seissler J; Scherbaum WA
    Horm Metab Res; 1998 Mar; 30(3):162-8. PubMed ID: 9566861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
    Takasu N; Yamashiro K; Komiya I; Ochi Y; Sato Y; Nagata A
    Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective Trial of Functional Thyrotropin Receptor Antibodies in Graves Disease.
    Kahaly GJ; Diana T; Kanitz M; Frommer L; Olivo PD
    J Clin Endocrinol Metab; 2020 Apr; 105(4):e1006-14. PubMed ID: 31865369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.